Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Is Deep Value ETF (DVP) a Strong ETF Right Now?

Smart Beta ETF report for DVP

Can Dental Growth Drive Henry Schein's (HSIC) Q4 Earnings?

Henry Schein (HSIC) is well placed to gain from digitalization in the global dental market.

Key Factors Likely to Shape CVS Health's (CVS) Q4 Earnings

CVS Health (CVS) expects drug price inflation, product launches and higher utilization to fuel growth in Q4.

Sheraz Mian headshot

3 Things to Know About Q4 Earnings Season

We continue to see the picture that emerged from the Q4 earnings season as not great, but it is not bad either.

Here's What Will Give Shape to Medtronic's (MDT) Q3 Earnings

Medtronic (MDT) is expected to maintain a decent market share in the core pacing backed by the continued uptake of Micra Transcatheter Pacing System in Q3.

Benjamin Rains headshot

What to Expect from CVS Health's Q4 Earnings, Revenue & Comps

Shares of CVS Health (CVS) have popped 4% in the last month and jumped 1.16% during regular trading Wednesday. But does this signal that investors expect good things from the pharmacy power's Q4 financial results that are due out before the opening bell on February 20?

CVS Health (CVS) Earnings Expected to Grow: Should You Buy?

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed at $65.10 in the latest trading session, marking a +0.14% move from the prior day.

Procter & Gamble to Widen Naturals Line With This is L. Buyout

Procter & Gamble (PG) is focusing on the fast-growing 'naturals' business line, with the acquisition of a natural ingredient-based women's products company, This is L.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $65.67, marking a -0.36% move from the previous day.

Why the Earnings Surprise Streak Could Continue for CVS Health (CVS)

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CVS Health (CVS) Gains As Market Dips: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $65.54, marking a +0.46% move from the previous day.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed the most recent trading day at $66.11, moving +1.83% from the previous trading session.

CVS Health's PBM Pharmacy Platform to Ride on Walmart Deal

Per the terms of the deal between CVS Health (CVS) and Walmart, the latter will continue to take part in the CVS Caremark PBM commercial and Managed Medicaid retail pharmacy networks.

Zacks.com featured expert Kevin Matras highlights: American Airlines, ArcBest, AmerisourceBergen, Cardinal Health and CVS Health

Zacks.com featured expert Kevin Matras highlights: American Airlines, ArcBest, AmerisourceBergen, Cardinal Health and CVS Health

5 Stocks in Focus After Recent Broker Rating Upgrades

The guidance to design a winning portfolio comes from brokers given their thorough understanding of the stock market.

Company News For Jan 16, 2019

Companies in the news are: DAL, CVS, WMT, WFC and UAL

Urmimala Biswas headshot

Amazon Fear Grips Retail Pharmacy Space, Alliances Continue

While Amazon is figuring out ways to expand in the multibillion dollar pharmacy industry, Walgreens and other industry players are ready to counter competition.

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $65.34, marking a -0.71% move from the previous day.

CVS Health Sees Hammer Chart Pattern: Time to Buy?

CVS Health Corporation (CVS) has been struggling lately, but the selling pressure may be coming to an end soon.

Zacks Value Trader Highlights: American Airlines, United Continental, Discovery, CVS and Dell Technologies

Zacks Value Trader Highlights: American Airlines, United Continental, Discovery, CVS and Dell Technologies

Tracey Ryniec headshot

5 Dirt Cheap Big Cap Stocks to Buy Now

With the 2018 sell off, some big cap stocks are now trading with P/Es under 10.

Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays

Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $68.53 in the latest trading session, marking a -0.12% move from the prior day.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $68.53 in the latest trading session, marking a -0.12% move from the prior day.